OP08 Long-term efficacy and pharmacodynamics of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) monoclonal antibody SHP647 in Crohn’s disease: the OPERA II study
G. D’Haens(Radboud University Nijmegen), W. Sandborn, S D Lee(University of Washington), D I Park(Kangbuk Samsung Hospital), Dino Tarabar(Military Medical Academy), Fabio Cataldi(Pfizer (United States)), Anindita Banerjee(Pfizer (United States)), Stefan Schreiber(Christian-Albrechts-Universität zu Kiel), E Louis, Y Wang(Takeda (United States)), Ken Gorelick(Pfizer (United States)), Péter Nagy(AstraZeneca (Sweden)), Steven W. Martin(Mississippi Delta Community College), J Klaus(University Hospital Ulm), Walter Reinisch(Medical University of Vienna), Xavier Hébuterne(Université Côte d'Azur), Maria Kłopocka(Nicolaus Copernicus University)
Cited by 3
Related Papers
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
|Nature Genetics|2009|1.4k
Paneth cells as a site of origin for intestinal inflammation
|Nature|2013|724